118 related articles for article (PubMed ID: 15587908)
1. [Assessment of the AgNORs count in serous ovarian cancer].
Gottwald L; Danilewicz M; Suzin J; Bieńkiewicz A
Ginekol Pol; 2004 Oct; 75(10):770-5. PubMed ID: 15587908
[TBL] [Abstract][Full Text] [Related]
2. [Assessment of the influence of chemotherapy on the nucleolar organizer regions (AgNORs) count in serous ovarian cancer cells].
Bieńkiewicz A; Gottwald L; Danilewicz M; Suzin J
Ginekol Pol; 2003 Sep; 74(9):677-82. PubMed ID: 14674107
[TBL] [Abstract][Full Text] [Related]
3. AgNORs count correlates better than grading with the effect of chemotherapy in serous ovarian cancer.
Gottwald L; Danilewicz M; Suzin J; Wójcik-Krowiranda K; Bieńkiewicz A
Pol J Pathol; 2003; 54(4):239-42. PubMed ID: 14998291
[TBL] [Abstract][Full Text] [Related]
4. The AgNORs count in predicting long-term survival in serous ovarian cancer.
Gottwald L; Danilewicz M; Fendler W; Suzin J; Spych M; Piekarski J; Tylinski W; Chalubinska J; Topczewska-Tylinska K; Cialkowska-Rysz A
Arch Med Sci; 2014 Feb; 10(1):84-90. PubMed ID: 24701219
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K
Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
[TBL] [Abstract][Full Text] [Related]
6. THE PROGNOSTIC SIGNIFICANCE OF P53, BCL2 AND MIB1 EXPRESSIONS RELATED WITH OTHER CLINICOPATHOLOGICAL VARIABLES IN SEROUS OVARIAN CARCINOMAS. A CLINICOPATHOLOGICAL STUDY IN PERITONEAL FLUIDS.
Kalogeraki A; Tamiolakis D; Matalliotaki C; Karvela-Kalogeraki I; Karvelas-Kalogerakis M; Segredakis J; Sinatkas V; Matalliotakis I
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):454-60. PubMed ID: 26204652
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of nucleolar organizer regions in normal epithelium, dysplasia, and squamous cell carcinoma of the oral cavity.
Xie X; Clausen OP; Sudbö J; Boysen M
Cancer; 1997 Jun; 79(11):2200-8. PubMed ID: 9179068
[TBL] [Abstract][Full Text] [Related]
8. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours.
Stemberger-Papić S; Stanković T; Vrdoljak-Mozetic D; Versa-Ostojić D; Krasević M; Stifter S; Audy-Jurković S
Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922
[TBL] [Abstract][Full Text] [Related]
9. Nucleolar organizer regions and prognosis in glottic squamous cell carcinoma.
Xie X; Stenersen TC; Clausen OP; Boysen M
Head Neck; 1997 Jan; 19(1):20-6. PubMed ID: 9030940
[TBL] [Abstract][Full Text] [Related]
10. The argyrophilic nucleolar organizer regions in ductal carcinoma in situ of the breast. The significance of ploidy and proliferative activity analysis using this silver staining technique.
Mourad WA; Setrakian S; Hales ML; Abdulla M; Trucco G
Cancer; 1994 Sep; 74(6):1739-45. PubMed ID: 8082076
[TBL] [Abstract][Full Text] [Related]
11. Two AgNOR counts in fine-needle aspirates of lymphoproliferative disorders compared with acridine orange flow cytometry.
Mourad WA; Katz RL; Sembera D; Atkinson EN; el-Naggar AK
Diagn Cytopathol; 1992; 8(2):128-34. PubMed ID: 1568410
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the argyrophilic nucleolar organizer region area/nucleus ratio in ovarian serous epithelial adenomas, borderline tumors and cancers.
Gottwald L; Danilewicz M; Suzin J; Wagrowska-Danilewicz M; Spych M; Tylinski W; Topczewska-Tylinska K; Piekarski J; Kazmierczak-Lukaszewicz S; Cialkowska-Rysz A
Arch Med Sci; 2013 Feb; 9(1):79-85. PubMed ID: 23515230
[TBL] [Abstract][Full Text] [Related]
13. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
14. Argyrophilic proteins of nucleolar organizer regions (AgNORs) in fallopian tube carcinomas.
Rabczyńiski JK; Kochman AT; Karmowski A; Woźniak ZM; Bronowicz A; Terpiłowski L
Clin Exp Obstet Gynecol; 2000; 27(2):125-8. PubMed ID: 10968353
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic significance of cellular DNA content and AgNOR count in ovarian cystadenoma].
Lu XL; Yi WM; Wang LF
Ai Zheng; 2003 Jan; 22(1):62-5. PubMed ID: 12561439
[TBL] [Abstract][Full Text] [Related]
16. The correlation of two argyrophilic nucleolar organizer region counting methods with bromodeoxyuridine-labeling index: a study of metastatic tumors of the brain.
Mourad WA; Connelly JH; Sembera DL; Atkinson EN; Bruner JM
Hum Pathol; 1993 Feb; 24(2):206-10. PubMed ID: 8432516
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of nucleolar organizer regions in ovarian epithelial tumors.
Criscuolo M; Martinelli AM; Migaldi M; Zunarelli E; Bergamaschi M; Falchi AM; De Gaetani C
Int J Gynecol Pathol; 1993 Jul; 12(3):259-63. PubMed ID: 8344763
[TBL] [Abstract][Full Text] [Related]
18. Correlation of two AgNOR counts with Ki-67 labeling index: a study in fine-needle aspirates of lymphoproliferative disorders and breast carcinoma.
Mourad WA; Sneige N; Katz RL; Ordóñez NG
Diagn Cytopathol; 1994; 10(2):113-9. PubMed ID: 8187588
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic significance of AgNORs expression in endometrial cancer].
Bojarowska K
Ginekol Pol; 2004 Jul; 75(7):522-7. PubMed ID: 15517771
[TBL] [Abstract][Full Text] [Related]
20. Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival.
Davidson B; Trope' CG; Wang TL; Shih IeM
Gynecol Oncol; 2006 Dec; 103(3):814-9. PubMed ID: 16844205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
